Lack of bioequivalence of gatifloxacin when coadministered with calcium-fortified orange juice in healthy volunteers

被引:9
作者
Wallace, AW [1 ]
Victory, JM [1 ]
Amsden, GW [1 ]
机构
[1] Bassett Healthcare, Clin Pharmacol Res Ctr, Dept Adult & Pediat Med, Cooperstown, NY 13326 USA
关键词
D O I
10.1177/0091270002239711
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previous work has demonstrated that the chelation interaction seen with ciprofloxacin when it is coadministered with antacids also happens when it is coadministered with calcium-fortified foods. This study was conducted to study whether this was a drug-specific finding or whether the interaction occurs with other members of the fluoroquinolone class of drugs. Sixteen healthy volunteers received single 400mg oral doses of gatifloxacin with 12 ounces each of Water, nonfortified orange juice, and calcium-fortified orange juice and had plasma samples drawn for assay over the subsequent 48 hours. Results demonstrated significant increases in total oral clearance (15%) and volume of distribution (13%) along with a matching significant decrease (12%) in exposure (AUC) when gatifloxacin was taken with the fortified juice.
引用
收藏
页码:92 / 96
页数:5
相关论文
共 15 条
[1]  
*BRIST MYERS SQUIB, 2000, TEQ PROD INF
[2]   Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors [J].
Cormet-Boyaka, E ;
Huneau, JF ;
Mordrelle, A ;
Boyaka, PN ;
Carbon, C ;
Rubinstein, E ;
Tomé, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2607-2611
[3]   Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine [J].
Dresser, GK ;
Bailey, DG ;
Leake, BF ;
Schwarz, UI ;
Dawson, PA ;
Freeman, DJ ;
Kim, RB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (01) :11-20
[4]  
*FDA, 2001, FOOD EFF BIOAV FED B
[5]   PHARMACODYNAMICS OF INTRAVENOUS CIPROFLOXACIN IN SERIOUSLY ILL-PATIENTS [J].
FORREST, A ;
NIX, DE ;
BALLOW, CH ;
GOSS, TF ;
BIRMINGHAM, MC ;
SCHENTAG, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1073-1081
[6]  
Ito T, 1997, J PHARMACOL EXP THER, V282, P955
[7]   CLINICAL AND CHEMICAL INTERACTIONS BETWEEN IRON PREPARATIONS AND CIPROFLOXACIN [J].
KARA, M ;
HASINOFF, BB ;
MCKAY, DW ;
CAMPBELL, NRC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (03) :257-261
[8]   Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium [J].
Lober, S ;
Ziege, S ;
Rau, M ;
Schreiber, G ;
Mignot, A ;
Koeppe, P ;
Lode, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1067-1071
[9]   Lack of Bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: A new twist on an old interaction [J].
Neuhofel, AL ;
Wilton, JH ;
Victory, JM ;
Hejmanowski, LG ;
Amsden, GW .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (04) :461-466
[10]   EFFECTS OF ALUMINUM AND MAGNESIUM ANTACIDS AND RANITIDINE ON THE ABSORPTION OF CIPROFLOXACIN [J].
NIX, DE ;
WATSON, WA ;
LENER, ME ;
FROST, RW ;
KROL, G ;
GOLDSTEIN, H ;
LETTIERI, J ;
SCHENTAG, JJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (06) :700-705